IMNM Gross Margin

The Gross Margin of Immunome Inc (IMNM) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

IMNM Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

IMNM Gross Margin - Peers Comparison

Ticker	Name	Value
ABUS	Arbutus Biopharma Corp	7775.20%
KZR	Kezar Life Sciences Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
VINC	Vincerx Pharma Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
MRNA	Moderna Inc	70.06%
OVID	Ovid Therapeutics Inc	7775.20%
UBX	UNITY Biotechnology Inc	7775.20%
BIVI	BioVie Inc	7775.20%
TRVN	Trevena Inc	46.56%
CABA	Cabaletta Bio Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
SVA.V	Sernova Corp	44.44%
EIGR	Eiger BioPharmaceuticals Inc	99.90%
FBRX	Forte Biosciences Inc	7775.20%
IMUX	Immunic Inc	7775.20%
ABBV	Abbvie Inc	69.99%
AMGN	Amgen Inc	61.53%
CBMG	Cellular Biomedicine Group Inc	81.65%
CKPT	Checkpoint Therapeutics Inc	7775.20%
LRMR	Larimar Therapeutics Inc	7775.20%
MNOV	MediciNova Inc	100.00%
ONCR	Oncorus Inc	7775.20%
PRQR	ProQR Therapeutics NV	7775.20%
VTGN	Vistagen Therapeutics Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
DBTX	Decibel Therapeutics Inc	7775.20%
GRTX	Galera Therapeutics Inc	7775.20%
LCTX	Lineage Cell Therapeutics Inc	96.48%
950200.KQ	Psomagen Inc	23.13%
CRDF	Cardiff Oncology Inc	100.00%
GILD	Gilead Sciences Inc	78.26%
NCNA	NuCana PLC	7775.20%
IBIO	iBio Inc	38.40%
RCAR	RenovaCare Inc	-